首页> 美国卫生研究院文献>other >Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations
【2h】

Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations

机译:质谱的表观遗传组蛋白修饰研究进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chromatin biology and epigenetics are scientific fields in rapid expansion due to their fundamental role in understanding cell development, heritable characters and progression of diseases. Histone post-translational modifications (PTMs) are major regulators of the epigenetic machinery, due to their ability to modulate gene expression, DNA repair and chromosome condensation. Large- scale strategies based on mass spectrometry have been impressively improved in the last decade, so that global changes of histone PTM abundances are quantifiable with nearly routine proteomics analyses and it is now possible to determine combinatorial patterns of modifications. Presented here is an overview of the most utilized and newly developed proteomics strategies for histone PTM characterization and a number of case studies where epigenetic mechanisms have been comprehensively characterized. Moreover, a number of current epigenetics therapies are illustrated, with an emphasis on cancer
机译:染色质生物学和表观遗传学是快速发展的科学领域,这是由于它们在理解细胞发育,遗传特性和疾病进展中的基本作用。组蛋白翻译后修饰(PTM)是表观遗传机制的主要调节因子,因为它们具有调节基因表达,DNA修复和染色体浓缩的能力。在过去的十年中,基于质谱的大规模策略已得到显着改善,因此组蛋白PTM丰度的全球变化可通过近乎常规的蛋白质组学分析进行量化,现在可以确定修饰的组合模式。本文概述了用于组蛋白PTM表征的最常用和最新开发的蛋白质组学策略,以及对表观遗传机制进行了全面表征的许多案例研究。此外,举例说明了许多当前的表观遗传学疗法,重点是癌症

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号